Earnings Call · Q3 FY2024·2024-11-03

Q3 24EPS +2.38%·Rev n/aQ2 24EPS +12.12%·Rev n/aQ1 24EPS +13.89%·Rev n/aQ4 23EPS +37.50%·Rev n/a⚠ consensus missing

Kymera Therapeutics, Inc. KYMR

Justine Koenigsberg — Investor Relations or Communications

Nello Mainolfi — Founder, President and CEO

Jared Gollob — Chief Medical Officer

Bruce Jacobs — Chief Financial Officer

−3.1%1d on move date−1.2% vs SPY3d−1.3%5d+3.8%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more KYMR calls or request research access.

More KYMR calls Browse calls Request research access